Featured Courses

Defining the therapeutic algorithm in patients with HR positive breast cancer - United States

Oncology

Course Description: At the end of this educational activity, you should have a clear picture of the latest clinical upda...

Module 2 - New Understanding of COPD Pathophysiology and Emerging Biologic Therapies

Pulmonary Disease

Course Description: This module covers recent advances in COPD management, including an update on pathophysiology, the e...

The Anti-seizure Medication Landscape and Their Effect on Non-seizure Symptoms

Neurology

Course Description: This module discusses the major anti-seizure medicines used for patients with DEEs and how they impa...

Understanding Obesity Management Through the Lens of Cultural Humility

Weight Management

Course Description: This activity covers understanding obesity management through the lens of cultural humility.

COURSES

ALL

Advancements in ADC Therapy for Metastatic Triple Negative and HR+/HER2- Breast Cancer Treatment

LAUNCH DATE: 23-Dec-2024

EXPIRATION DATE: 23-Dec-2025

Oncology

CREDITS

0.75 AMA PRA Category 1 Credit(s)™

Antibody Drug Conjugates (ADC) - United States

LAUNCH DATE: 11-Sep-2024

EXPIRATION DATE: 11-Sep-2025

Oncology

CREDITS

0.50 AMA PRA Category 1 Credit(s)™

0.50 ANCC Contact Hours

0.50 ACPE

0.50 Pharmacology

Collaborative Care with NSS (Non-Seizure Symptoms) in Mind

LAUNCH DATE: 30-Sep-2024

EXPIRATION DATE: 30-Sep-2025

Neurology

CREDITS

0.25 AMA PRA Category 1 Credit(s)™